Devi Shetty's low-cost hospital network, whose Mazumdar Shaw cancer centre in Bengaluru applies high-volume, low-price surgery and transplant to cancer and hosts India's second CAR-T developer.
Narayana Health began in 2001 when cardiac surgeon Devi Shetty founded Narayana Hrudayalaya at Bommasandra outside Bengaluru; it grew into a listed group of 24 hospitals and 7 heart centres across India and the Cayman Islands, known for driving procedure costs down through volume and process. Cancer care is concentrated at the Mazumdar Shaw Medical Centre at Narayana Health City, established in 2009 with Biocon founder Kiran Mazumdar-Shaw as a 1,400-bed cancer and multispecialty campus, with large bone marrow transplant, paediatric haematology-oncology, radiation and surgical programmes. The campus is also home to Immuneel Therapeutics, whose CAR-T Qartemi was developed and trialled there.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Narayana Health, including child institutions. 111 works · 260 citations · 74% open access · 8% clinical trials · 1% reviews.
The cardiac surgeon who showed that high-volume hospitals can cut the price of complex care by an order of magnitude, a model now applied to cancer at Narayana Health's Bengaluru campus.
Founded Biocon in a garage in 1978 and turned it into the company behind the world's first approved trastuzumab biosimilar, and co-founded a 1,400-bed cancer campus in Bengaluru.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Head and neck squamous cell carcinoma, Diffuse large B-cell lymphoma.
Shares Immuneel Therapeutics, IMAGINE (varnimcabtagene autoleucel, Immuneel), Varnimcabtagene autoleucel, CAR-T cell therapy.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.